Sona Asset Management US LLC Invests $2.17 Million in GP-Act III Acquisition Corp. $GPAT

Sona Asset Management US LLC bought a new stake in shares of GP-Act III Acquisition Corp. (NASDAQ:GPATFree Report) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 200,000 shares of the company’s stock, valued at approximately $2,168,000.

Several other institutional investors and hedge funds have also recently modified their holdings of GPAT. Bank of America Corp DE purchased a new position in GP-Act III Acquisition during the third quarter worth approximately $85,000. Cannon Global Investment Management LLC increased its position in shares of GP-Act III Acquisition by 38.1% in the fourth quarter. Cannon Global Investment Management LLC now owns 14,500 shares of the company’s stock valued at $155,000 after buying an additional 4,000 shares in the last quarter. Schonfeld Strategic Advisors LLC purchased a new stake in shares of GP-Act III Acquisition in the third quarter valued at approximately $203,000. Lineage Point Capital LP acquired a new position in shares of GP-Act III Acquisition during the 4th quarter worth approximately $695,000. Finally, Shaolin Capital Management LLC acquired a new position in shares of GP-Act III Acquisition during the 2nd quarter worth approximately $1,055,000.

GP-Act III Acquisition Stock Performance

GPAT opened at $11.05 on Monday. GP-Act III Acquisition Corp. has a twelve month low of $10.50 and a twelve month high of $12.00. The company has a 50-day moving average price of $10.95 and a 200 day moving average price of $10.85.

GP-Act III Acquisition (NASDAQ:GPATGet Free Report) last posted its quarterly earnings data on Thursday, May 14th. The company reported $0.06 earnings per share (EPS) for the quarter.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reissued a “sell (d)” rating on shares of GP-Act III Acquisition in a research note on Friday, July 17th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company presently has an average rating of “Sell”.

Get Our Latest Stock Analysis on GPAT

GP-Act III Acquisition Company Profile

(Free Report)

GP-Act III Acquisition Corp is a special purpose acquisition company organized as a Delaware corporation that completed its initial public offering in 2021. As a blank-check company, it has no commercial operations of its own and was formed to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

The company’s primary business activity is to identify and acquire a target company in sectors such as technology, business services, healthcare or other high-growth industries.

Further Reading

Institutional Ownership by Quarter for GP-Act III Acquisition (NASDAQ:GPAT)

Receive News & Ratings for GP-Act III Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GP-Act III Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.